5 news items
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
HOTH
27 Mar 24
in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
HOTH
27 Mar 24
to leveraging top-tier computational resources and AI expertise to advance its research and development efforts in therapeutic discovery
Hoth Therapeutics Announces Data In Completed Study Of Alzheimer's Disease Pre-Clinical Treatment With HT-ALZ
HOTH
19 Mar 24
.Hoth Therapeutics remains committed to further research and development of HT-ALZ, including detailed analyses of its effects on microglial
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
HOTH
19 Mar 24
committed to further research and development of HT-ALZ, including detailed analyses of its effects on microglial activation and brain inflammation
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
HOTH
29 Feb 24
will greatly add value and further protect our expanding research and development of life-changing therapeutics," said
- Prev
- 1
- Next